Financial Ratios

TRIOCHEM PRODUCTS LTD.

NSE : NABSE : 512101ISIN CODE : INE331E01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE17.400 (0 %)
PREV CLOSE ( ) 17.40
OPEN PRICE ( ) 17.40
BID PRICE (QTY) 17.40 (1300)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5
TODAY'S LOW / HIGH ( )17.40 17.40
52 WK LOW / HIGH ( ) 17.417.4
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-36.1353.99-18.24138.8930.32
   CEPS(Rs)-31.8458.86-12.58145.7038.71
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)473.36532.51478.04497.00358.19
   Tax Rate(%)24.3424.9823.0825.2428.53
Margin Ratios
   Core EBITDA Margin(%)15.16-2.6622.5913.35
   EBIT Margin(%)20.21-2.7024.0912.14
   Pre Tax Margin(%)19.99-4.1722.728.41
   PAT Margin (%)15.00-3.2116.996.01
   Cash Profit Margin (%)16.35-2.2117.827.68
Performance Ratios
   ROA(%)-7.1110.42-3.1221.425.51
   ROE(%)-7.1810.69-3.7432.488.84
   ROCE(%)-9.4814.40-2.8532.9912.05
   Asset Turnover(x)0.000.690.971.260.92
   Sales/Fixed Asset(x)0.004.647.4810.826.69
   Working Capital/Sales(x)0.000.751.311.821.63
Efficiency Ratios
   Fixed Capital/Sales(x)0.220.130.090.15
   Receivable days0.00180.55143.3098.38
   Inventory Days18.7631.52101.39262.93
   Payable days14.3615.4414.5523.27
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)-1.31-0.570.110.47
   EV/Core EBITDA(x)0.67-6.0833.550.443.40
   EV/EBIT(x)0.61-6.4921.160.453.86
   EV/CE(x)-0.06-0.87-0.660.130.38
   M Cap / Sales0.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-100.00-36.71-30.4262.14-64.69
   Core EBITDA Growth(%)-155.91902.49-104.75192.76-59.55
   EBIT Growth(%)-165.54574.37-107.79221.74-62.20
   PAT Growth(%)-166.91395.93-113.14358.06-70.92
   EPS Growth(%)-166.91395.93-113.14358.06-70.92
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.210.66
   Current Ratio(x)5.3856.6328.203.542.21
   Quick Ratio(x)5.1656.3826.013.180.68
   Interest Cover(x)-778.9391.42-1.8317.683.26
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.